A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'
- PMID: 38768040
- PMCID: PMC11325988
- DOI: 10.1097/JS9.0000000000001548
A commentary on 'The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs'
Conflict of interest statement
The authors declare no conflicts of interes.
Similar articles
-
Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis.JAMA. 2003 Jan 8;289(2):210-6. doi: 10.1001/jama.289.2.210. JAMA. 2003. PMID: 12517232
-
The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs.Int J Surg. 2024 Jun 1;110(6):3937-3945. doi: 10.1097/JS9.0000000000001381. Int J Surg. 2024. PMID: 38573101 Free PMC article.
-
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients.Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012. Int J Neuropsychopharmacol. 2017. PMID: 28201726 Free PMC article.
-
Galantamine for Alzheimer's disease.Cochrane Database Syst Rev. 2002;(3):CD001747. doi: 10.1002/14651858.CD001747. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. doi: 10.1002/14651858.CD001747.pub2. PMID: 12137632 Updated.
-
Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3. Cochrane Database Syst Rev. 2018. PMID: 29923184 Free PMC article.
References
-
- Zhang Y, Sun Y, Hu X, et al. . The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs. Int J Surg 2024;3. [Epub ahead of print]. doi:10.1097/JS9.0000000000001381 - DOI - PMC - PubMed
-
- ADLARITY (donepezil transdermal system), Prescribing information, 2022. Accessed 3 April 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical